Women's Health Trial Tracker — 2014

Name: Women's Health Trial Tracker
Creator: 1 Women’s Health
License: United States government work; public domain unless the source record says otherwise.

Record	Record Date	Vuga Group	Change Status	Recency Days
Group Versus Individual Physiotherapy for Urinary Incontinence in Aging Women	01/20/2014	INTERVENTIONAL	not-comparable	4,646.75
Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer	01/23/2014	OBSERVATIONAL	not-comparable	4,643.75
TAILORx Tissue Bank	01/31/2014	OBSERVATIONAL	not-comparable	4,635.75
Discovering the Antecedents of Rheumatoid Arthritis Flare	01/31/2014	OBSERVATIONAL	not-comparable	4,635.75
A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread	02/06/2014	INTERVENTIONAL	not-comparable	4,629.75
Mother and Infant Home Visiting Program Evaluation	02/24/2014	INTERVENTIONAL	not-comparable	4,611.75
The Role of Lifestyle Factors in Breast Cancer-Related Outcomes	03/06/2014	INTERVENTIONAL	not-comparable	4,601.75
Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Breast Cancer	03/17/2014	INTERVENTIONAL	not-comparable	4,590.75
Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry	04/01/2014	OBSERVATIONAL	not-comparable	4,575.75
Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer	04/02/2014	INTERVENTIONAL	not-comparable	4,574.75
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project	04/03/2014	OBSERVATIONAL	not-comparable	4,573.75
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer	04/08/2014	INTERVENTIONAL	not-comparable	4,568.75
Cognition in Older Breast Cancer Survivors: Treatment Exposure, APOE and Smoking History	04/24/2014	OBSERVATIONAL	not-comparable	4,552.75
HOT: HIPEC in Ovarian Cancer as Initial Treatment	04/28/2014	INTERVENTIONAL	not-comparable	4,548.75
European Active Surveillance Study of LCS12	05/26/2014	OBSERVATIONAL	not-comparable	4,520.75
Effectiveness of Cervical Screening in HPV Vaccinated Women	05/29/2014	INTERVENTIONAL	not-comparable	4,517.75
Randomized Controlled Trial Evaluating the Role of Exercise in Women Undergoing Treatment for Breast Cancer	06/12/2014	INTERVENTIONAL	not-comparable	4,503.75
Sentinel Node Vs Observation After Axillary Ultra-souND	06/19/2014	INTERVENTIONAL	not-comparable	4,496.75
Incidence of Difficult Airway and Difficult Neuraxial Placement in Obstetric Patients	07/17/2014	OBSERVATIONAL	not-comparable	4,468.75
Functional Snack Foods With Safflower Oil and Soy in Postmenopausal Women Having Metabolic Syndrome	07/24/2014	INTERVENTIONAL	not-comparable	4,461.75
Pazopanib Vs. Pazopanib Plus Gemcitabine	07/30/2014	INTERVENTIONAL	not-comparable	4,455.75
Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy	07/30/2014	INTERVENTIONAL	not-comparable	4,455.75
mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian	08/05/2014	INTERVENTIONAL	not-comparable	4,449.75
Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients	08/21/2014	INTERVENTIONAL	not-comparable	4,433.75
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer	08/27/2014	INTERVENTIONAL	not-comparable	4,427.75
A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers	09/12/2014	INTERVENTIONAL	not-comparable	4,411.75
Biomarkerscreening in Cervical Cancer and Its Preinvasive Lesions	09/12/2014	OBSERVATIONAL	not-comparable	4,411.75
Energy Balance and Breast Cancer Aspects-II	09/16/2014	INTERVENTIONAL	not-comparable	4,407.75
A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer	09/23/2014	INTERVENTIONAL	not-comparable	4,400.75
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer	10/06/2014	INTERVENTIONAL	not-comparable	4,387.75
Follow-up of Early Breast Cancer by Dynamic Evaluation of CEA and CA 15.3 Followed by 18FDG-PET	10/10/2014	INTERVENTIONAL	not-comparable	4,383.75
Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial	10/28/2014	INTERVENTIONAL	not-comparable	4,365.75
Comparison of Regimens MPIB, CIPCEA, PCEA	10/30/2014	INTERVENTIONAL	not-comparable	4,363.75
[18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer	11/06/2014	INTERVENTIONAL	not-comparable	4,356.75
Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer	11/06/2014	INTERVENTIONAL	not-comparable	4,356.75
DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics	11/11/2014	OBSERVATIONAL	not-comparable	4,351.75
TARGIT-C(Consolidation) Prospective Phase IV Study of IORT in Patients With Small Breast Cancer	11/14/2014	INTERVENTIONAL	not-comparable	4,348.75
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer	11/14/2014	INTERVENTIONAL	not-comparable	4,348.75
Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention	11/20/2014	INTERVENTIONAL	not-comparable	4,342.75
Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant	11/21/2014	INTERVENTIONAL	not-comparable	4,341.75
MRI Assessment of Placental Health	11/21/2014	OBSERVATIONAL	not-comparable	4,341.75
Development of a Novel Stress Testing Protocol to Define the Relationship Between Coronary Microvascular Dysfunction and Diastology in Women With Angina But No Evidence of Obstructive Coronary Artery Disease	11/26/2014	INTERVENTIONAL	not-comparable	4,336.75
MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study	11/26/2014	OBSERVATIONAL	not-comparable	4,336.75
Evaluation of Myocardial Changes During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRI	12/03/2014	OBSERVATIONAL	not-comparable	4,329.75
Sickle Cell Hemoglobinopathies and Bone Health	12/03/2014	OBSERVATIONAL	not-comparable	4,329.75
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer	12/04/2014	INTERVENTIONAL	not-comparable	4,328.75
Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer	12/09/2014	INTERVENTIONAL	not-comparable	4,323.75
Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer	12/11/2014	INTERVENTIONAL	not-comparable	4,321.75
Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis	12/12/2014	OBSERVATIONAL	not-comparable	4,320.75
Impact of Unrestrictive Exercise Following Mid-Urethral Sling Surgery	12/12/2014	INTERVENTIONAL	not-comparable	4,320.75
Ice Versus EMLA for Pain in Laser Hair Removal	12/17/2014	INTERVENTIONAL	not-comparable	4,315.75
Study of Placental Function in Healthy and Pathological Pregnancies	12/19/2014	OBSERVATIONAL	not-comparable	4,313.75
Early Salpingectomy (Tubectomy) With Delayed Oophorectomy in BRCA1/2 Gene Mutation Carriers	12/22/2014	INTERVENTIONAL	not-comparable	4,310.75
Tc99m Sestamibi Molecular Breast Imaging	12/24/2014	INTERVENTIONAL	not-comparable	4,308.75
Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia	12/31/2014	INTERVENTIONAL	not-comparable	4,301.75